NASDAQ · SERVICES-MEDICAL LABORATORIES · SMALL CAP
Personalis, Inc. PSNL
9 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY
Revenue · FY2025
$69.6M
▼ 17.7% vs FY2024
EPS · FY25
$-0.91
Dividend / sh · FY25
—
Payout · FY25
—
ROE · FY25
-35.0%
Net margin · FY25
-116.7%
Dividend coverage
—
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 69.6M
Revenue, FY2025 · full 9-year series below
Revenue
Net income
The company lost 117 cents on every revenue dollar this year.
Per share
USD -0.91
Diluted EPS, FY2025
EPS
The company pays no cash dividend.
Profitability
-35.0%
Return on equity, FY2025
ROE
Operating margin-126.4%
Net margin-116.7%
Return on assets-26.9%
Each USD of equity lost 35 cents this year.
Returned to shareholders
—
returned in FY2025 · dividends + net buybacks
Dividends paid—
Net buybacks—
Share of profit—
Consecutive raises—
Growth
−2.4% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
+2.3%
−2.4%
Compound annual rates per period — left blank where the series crosses a loss.
Share base
0.10B
Shares outstanding, FY2025
Change, 5 years—
Change, 10 years—
A share split breaks the comparison across the period, so we leave it out.
Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 334.2M
total assets, end of FY2025
Total assetsUSD 334.2M
EquityUSD 261.2M
CashUSD 124.2M
Current ratio6.76×
Equity funds 78% of total assets.
History
9 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
2021
2020
2019
2018
2017
Revenue $B
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.0
0.0
Operating income $B
−0.1
−0.1
−0.1
−0.1
−0.1
−0.0
−0.0
−0.0
−0.0
EBITDA $B
−0.1
−0.1
−0.1
−0.1
−0.1
−0.0
−0.0
−0.0
−0.0
Income tax $B
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Net income $B
−0.1
−0.1
−0.1
−0.1
−0.1
−0.0
−0.0
−0.0
−0.0
EPS, diluted $
−0.91
−1.37
−2.25
−2.48
−1.49
−1.20
−1.39
−6.49
−7.78
Dividend / sh $
·
·
·
·
·
·
·
·
·
Payout %
·
·
·
·
·
·
·
·
·
ROE %
−35.0
−48.9
−62.3
−42.9
−25.8
−27.4
−16611.9
·
·
Shares out B
0.10
0.09
0.05
0.05
0.04
0.04
0.03
0.00
·
Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.
How we verifyAUDITED
25 of 25
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity
Every figure was compared against the original statement: 0 failures and 0 presentation gaps.
What we don’t show
We’d rather say what’s missing than fill the gap with an estimate.
P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed